Position in QGEN
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$300,053
+$62,576 QoQ
Shares Held
7,674
+29.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#211
of 332 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $154,112,137 across 25 Diagnostics & Research names. QGEN ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
51,463 | $25,801,489 | |
| 2 | DHR |
Danaher Corp /De/
|
119,360 | $22,735,692 | |
| 3 | DGX |
Quest Diagnostics Inc
|
104,301 | $22,106,596 | |
| 4 | NTRA |
Natera, Inc.
|
63,607 | $17,266,120 | |
| 5 | A |
Agilent Technologies, Inc.
|
93,804 | $12,459,985 | |
| 6 | ILMN |
Illumina, Inc.
|
61,667 | $10,842,908 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
13,882 | $7,351,768 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
13,662 | $7,192,223 |
All Filings in QGEN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,053 | 7,674 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $237,477 | 5,931 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $336,150 | 7,475 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $297,568 | 6,660 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $423,456 | 8,811 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $219,700 | 5,472 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $215,168 | 4,832 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $215,409 | 4,727 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $399,518 | 9,723 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $266,237 | 6,193 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||